Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Ljungman P) "

Sökning: WFRF:(Ljungman P)

Sortera/gruppera träfflistan
  • Waszczuk-Gajda, A, et al. (författare)
  • Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study
  • 2022
  • Ingår i: Journal of clinical medicine. - : MDPI AG. - 2077-0383. ; 11:12
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: The main goal of this post hoc analysis of the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study was to evaluate the rate of short- and long-term infectious and non-infectious complications occurring after ASCT in patients with multiple myeloma (MM). Methods: The analysis included all patients with MM from the CALM study who underwent ≥1 ASCT. The primary endpoint of the analysis was to determine the rate of infectious and non-infectious complications after ASCT and to compare them in three time periods: 0–100 days, 101 days–1 year, and >1 year after the first transplant. Results: The analysis included a total of 3552 patients followed up for a median of 56.7 months (range 0.4–108.1). Complication rates decreased with the time from ASCT with 24.85 cases per 100 patient-years from day 0 to 100 days after the transplant, and <2.31 cases per 100 patient-years from the 101st day. At 100 days after ASC T, 45.7% of patients had complications, with infectious events being twice as frequent as non-infectious complications. Bacterial infections (6.5 cases per 100 patient-years, 95% CI: 6.1–7.0) and gastrointestinal complications (4.7 cases per 100 patient-years, 95% CI: 4.3–5.1) were the most common early events. The pattern of complications changed with time from ASCT. The presence of complications after ASCT was not associated with overall survival. Conclusions: Our data provide a solid basis for comparing ASCT-related complications to those caused by emerging treatments in multiple myeloma, such as CAR T-cell therapy and other immunotherapies.
  • Alchi, B, et al. (författare)
  • Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry
  • 2013
  • Ingår i: Lupus. - : SAGE Publications. - 1477-0962 .- 0961-2033. ; 22:3, s. 245-253
  • Tidskriftsartikel (refereegranskat)abstract
    • Patients with systemic lupus erythematosus (SLE) refractory to conventional immunosuppression suffer substantial morbidity and mortality due to active disease and treatment toxicity. Immunoablation followed by autologous stem cell transplantation (ASCT) is a novel therapeutic strategy that potentially offers new hope to these patients. Methods This retrospective survey reviews the efficacy and safety of ASCT in 28 SLE patients from eight centres reported to the European Group for Blood and Marrow Transplantation (EBMT) registry between 2001 and 2008. Results Median disease duration before ASCT was 52 (nine to 396) months, 25/28 SLE patients (89%) were female, age 29 (16–48) years. At the time of ASCT, eight (one to 11) American College of Rheumatology (ACR) diagnostic criteria for SLE were present and 17 (60%) patients had nephritis. Peripheral blood stem cells were mobilized with cyclophosphamide and granulocyte-colony stimulating factor in 93% of patients, and ex vivo CD34 stem cell selection was performed in 36%. Conditioning regimens were employed with either low ( n = 10) or intermediate (18) intensities. With a median follow-up of 38 (one to 110) months after ASCT, the five-year overall survival was 81 ± 8%, disease-free survival was 29 ± 9%, relapse incidence (RI) was 56 ± 11% and non-relapse mortality was 15 ± 7%. Graft manipulation by CD34+ selection was associated with a lower RI ( p = 0.001) on univariate analysis. There were five deaths within two years after ASCT: three caused by infection, one by secondary autoimmune disease and one by progressive SLE. Conclusions Our data further support the concept of immunoablation and ASCT to re-induce long-term clinical and serologic remissions in refractory SLE patients even in the absence of maintenance therapy. This study also suggests a beneficial effect of ex vivo graft manipulation on prevention of relapses post-transplantation in SLE.
Skapa referenser, mejla, bekava och länka
Typ av publikation
tidskriftsartikel (534)
konferensbidrag (181)
bokkapitel (1)
Typ av innehåll
refereegranskat (498)
övrigt vetenskapligt (218)
Ljungman, P (666)
Ringden, O (144)
Remberger, M. (89)
Mattsson, J. (76)
Winiarski, J (64)
Aschan, J (61)
visa fler...
Cordonnier, C. (59)
Einsele, H (54)
Hagglund, H (50)
de la Camara, R (48)
Styczynski, J (46)
Cesaro, S (43)
Kroger, N (38)
Volin, L (38)
Maertens, J (37)
Gahrton, G (36)
Lonnqvist, B (36)
Mikulska, M (36)
Niederwieser, D (33)
Socie, G (33)
Hassan, M (32)
Bjorkstrand, B (32)
Gratwohl, A (31)
Apperley, J (30)
Tridello, G (29)
Sparrelid, E (29)
Bellander, T (28)
Nagler, A (27)
Yakoub-Agha, I (27)
Passweg, J (26)
Mohty, M (25)
Pershagen, G (24)
Bacigalupo, A (24)
Finke, J. (23)
Labopin, M (23)
Michallet, M (21)
Engelhard, D (21)
Averbuch, D (20)
Martino, R (20)
Lenhoff, S (20)
Chevallier, P. (19)
Barkholt, L (18)
Le Blanc, K (18)
van Biezen, A (18)
Hassan, Z. (17)
Nilsson, C (17)
Uhlin, M. (17)
Dalianis, T (17)
Stafoggia, M (17)
Locasciulli, A (17)
visa färre...
Karolinska Institutet (676)
Uppsala universitet (47)
Göteborgs universitet (27)
Lunds universitet (9)
Umeå universitet (6)
Linköpings universitet (6)
visa fler...
Röda Korsets Högskola (4)
Stockholms universitet (3)
Örebro universitet (3)
Karlstads universitet (3)
Högskolan Dalarna (2)
Sophiahemmet Högskola (2)
Kungliga Tekniska Högskolan (1)
Mälardalens universitet (1)
visa färre...
Engelska (714)
Svenska (1)
Tyska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (51)
Naturvetenskap (1)
Samhällsvetenskap (1)


Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy